Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    ARUBA
Show Display Options
Rank Status Study
1 Completed Aruba Aloe Formula F-BC-096 in the Treatment of Split Thickness Donor Site After Wound Closure
Condition: Wounds
Interventions: Other: Nivea Cream for scar hydration;   Other: Aloë Vera FORMULA F-BC-096 for scar hydration;   Other: Eucerin Calming cream for scar hydration;   Other: Aloë Vera with modified preservative for scar hydration
2 Suspended Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure
Condition: Hydration of Scars
Intervention: Drug: Application of Aruba Aloë formula F-BC-096 or control
3 Active, not recruiting A Randomized Trial of Unruptured Brain AVMs
Condition: Unruptured Brain Arteriovenous Malformation
Intervention: Procedure: invasive therapy [endovascular procedures, neurosurgery, or radiotherapy, alone or in combination]
4 Unknown  High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT

Indicates status has not been verified in more than two years